Libra Infusions Limited announcements
229 Dhaka Stock Exchange announcements for Libra Infusions Limited (LIBRAINFU) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2017 (12).
- Resumption after record date
Trading of the shares of the Company will resume on 19.11.2017 after record date.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. (7.04) for July-September, 2017 as against Tk. (5.79) for July-September, 2016; NOCFPS was Tk. 6.87 for July-September, 2017 as against Tk. (0.70) for July-September, 2016. NAV per share was Tk. 1,571.00 as on September 30, 2017 and Tk. 1,578.00 as on June 30, 2017.
- Suspension for Record Date
Trading of the shares of the Company will remain suspended on record date i.e., 16.11.2017.
- Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 14.11.2017 to 15.11.2017. Trading of the shares of the Company will remain suspended on record date i.e., 16.11.2017.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2017 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2017.
- Dividend Declaration
The Board of Directors has recommended 30% cash dividend for the year ended on June 30, 2017. Date of AGM: 20.12.2017, Time: 11:00 AM, Venue: Factory Premises of the Company I/7, Mirpur Industrial Estate, Rupnagar Section-2, Dhaka-1216. Record Date: 16.11.2017. The Company has also reported EPS of Tk. 4.86, NAV per share of Tk. 1,578.00 and NOCFPS of Tk. 1.75 for the year ended on June 30, 2017 as against Tk. 4.65, Tk. 1,576.00 and Tk. 56.49 respectively for the same period of the previous year.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (26.10.2017) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 25, 2017 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2017.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 4.10 for January-March, 2017 as against Tk. 2.95 for January-March, 2016; EPS was Tk. 4.88 for July, 2016-March, 2017 as against Tk. 5.64 for July, 2015-March, 2016. NOCFPS was Tk. 6.66 for July, 2016-March, 2017 as against Tk. 35.21 for July, 2015-March, 2016. NAV per share was Tk. 1,580.47 as of March 31, 2017 and Tk. 1,577.14 as of March 31, 2016.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 26, 2017 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2017.
- Q2
EPS was Tk. 4.74 for October-December, 2016 as against Tk. 8.14 for October-December, 2015; EPS was Tk. 0.78 for July-December, 2016 as against Tk. 2.69 for July-December, 2015. NOCFPS was Tk. 2.28 for July-December, 2016 as against Tk. 43.51 for July-December, 2015. NAV per share was Tk. 1,576.37 as on December 31, 2016 and Tk. 1,575.64 as on December 31, 2015.
- Qualified Opinion
The auditor of the company has given the following "Qualified Opinion" in the audit report of the company for the year ended on 30 June 2016: Basis for Qualified Opinion: 1. The Company is pursuing through a legal process for a claim of TK. 1,572,058,661 on account of loss damage and compensation etc. due to improper banking policy of Al-Arafah Islami Bank Limited. The Company presented the said claim as other receivable (Note no: 07) with a contra effect in Creditors and other payables (Note no: 18) which is not in line with BAS. 2. Though the Company has profit but the company neither share profit nor paid any advance to Al-Arafah Bank Limited against their investment of TK. 831,224,856 which comprises of Long term investment TK. 305,808,090, Term Investment Tk. 277,161,631 and short term investment Tk. 248,255,135. However, the company paid advances @ 11% as per sanction advice which has shown under finance cost in last year. In this connection we refer note no. 25 of the financial statements. 3. The Company uses revolution model for presentation of non-current assets but last revolution was conducted in the year 2010 and present fair market value of the same assets differs materially from the values shown in the financial statements. In this connection we refer note no. 3.2 of the financial statements. 4. Depreciation on non-current assets of Unit 2 was not charged as per BAS 16 since inception. In this connection we refer note no. 3.1 of the financial statements. 5. Deferred tax calculation has not been produced to us and as a result, we are unable to verify the same.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.